Published in J Thromb Haemost on July 01, 2011
CLEC-2 is required for development and maintenance of lymph nodes. Blood (2014) 1.64
Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation. Blood (2014) 1.48
Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol (2012) 1.45
CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood (2014) 1.42
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood (2011) 1.30
Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol (2013) 1.23
The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat Immunol (2014) 1.19
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries. Adv Hematol (2012) 1.01
Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue. J Biol Chem (2013) 0.99
Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2. J Thromb Haemost (2012) 0.97
Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res (2014) 0.87
Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis. Curr Top Med Chem (2013) 0.82
CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity. J Clin Invest (2016) 0.81
Why do we study animal toxins? Dongwuxue Yanjiu (2015) 0.77
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis. Oncotarget (2015) 0.77
Functional expression of the Fc-fused extracellular domains of group II membrane proteins. Glycoconj J (2014) 0.76
SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice. Blood (2014) 0.76
ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets. Cell Death Differ (2017) 0.75
The snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2). Toxins (Basel) (2013) 0.75
A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis. Sci Rep (2017) 0.75
C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets. Biochem Pharmacol (2014) 0.75
CLEC-2 and podoplanin, partners again. Blood (2016) 0.75
PDGF upregulates CLEC-2 to induce T regulatory cells. Oncotarget (2015) 0.75
Cancer-associated pathways and biomarkers of venous thrombosis. Blood (2017) 0.75
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun (1999) 3.03
The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology (1984) 2.65
Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (1997) 2.51
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature (1997) 2.46
The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet (1992) 1.97
Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res (2001) 1.79
Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun (1987) 1.69
The Fate of Micrococcus Aureus introduced into the Blood Stream of Dogs. J Med Res (1917) 1.52
Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril (2001) 1.44
Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood (2000) 1.44
Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens (2012) 1.44
Utility of duplex Doppler ultrasound in evaluating portal hypertension in children. J Pediatr Gastroenterol Nutr (1995) 1.40
Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature (1994) 1.37
[Bladder instillation of adriamycin in the treatment of bladder tumors. Report 1: Clinical results (author's transl)]. Nihon Hinyokika Gakkai Zasshi (1977) 1.36
Studies on the structure of water using two-dimensional near-infrared correlation spectroscopy and principal component analysis. Anal Chem (2001) 1.35
Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia (1989) 1.33
IgE class-specific suppressor T cells and factors in humans. J Immunol (1983) 1.31
Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol (2004) 1.31
Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat (2001) 1.29
Quantitative relation of urinary phenol levels to breathzone benzene concentrations: a factory survey. Br J Ind Med (1986) 1.28
Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood (2001) 1.28
Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr (1992) 1.26
Generation of the topa quinone cofactor in bacterial monoamine oxidase by cupric ion-dependent autooxidation of a specific tyrosyl residue. FEBS Lett (1994) 1.24
Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol (1999) 1.24
Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion (1995) 1.22
Amino acid sequence of a purothionin homolog from barley flour. J Biochem (1980) 1.21
Phenytoin-induced orofacial dyskinesia. A case report. J Neurol (1985) 1.19
Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut (1993) 1.19
Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet (1983) 1.19
Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer (1997) 1.18
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost (2006) 1.17
The actions of interferon and antiinflammatory agents of induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochem Biophys Res Commun (1987) 1.17
Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells. Blood (1999) 1.14
Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation (1994) 1.14
Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology (1997) 1.12
Two-dimensional visible/near-infrared correlation spectroscopy study of thermal treatment of chicken meats. J Agric Food Chem (2000) 1.10
A selective medium for isolation and presumptive identification of the Bacteriodes fragilis group. Microbiol Immunol (1983) 1.09
Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol (1991) 1.08
Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology (Berl) (1991) 1.07
Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation (1995) 1.07
Kawasaki disease: cardiac problems and management. Pediatr Rev (1988) 1.06
Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardized approach. Circulation (1995) 1.05
Comparison of hepatitis C virus markers in patients with NANB hepatitis. J Virol Methods (1992) 1.04
Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey. Brain Res (1994) 1.03
Successful treatment of neonatal aneurysmal dilatation of the vein of Galen: the role of prenatal diagnosis and trans-arterial embolization. Neuroradiology (1992) 1.03
Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets. Blood (1997) 1.03
Intravesical adriamycin chemotherapy in bladder cancer. Cancer Chemother Pharmacol (1983) 1.02
G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. J Biol Chem (2000) 1.01
Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc Res (2000) 1.01
Simultaneous determination of uric and ascorbic acids in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Anal Biochem (1984) 1.01
Epidemiology of hepatitis C virus in Japan: role in chronic liver disease and hepatocellular carcinoma. J Gastroenterol Hepatol (1991) 1.01
Melatonin in rat pineal, plasma, and urine: 24-hour rhythmicity and effect of chlorpromazine. Endocrinology (1976) 1.01
Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol (2000) 1.00
Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors. Cancer Chemother Pharmacol (1986) 1.00
Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum. J Immunol (1967) 0.99
FT-IR and near-infrared FT-Raman studies of the secondary structure of insulinotropin in the solid state: alpha-helix to beta-sheet conversion induced by phenol and/or by high shear force. J Pharm Sci (1994) 0.98
Analgesic component of Notopterygium incisum Ting. Chem Pharm Bull (Tokyo) (1993) 0.97
Biotyping of Propionibacterium acnes isolated from normal human facial skin. Appl Environ Microbiol (1979) 0.97
Involvement of dendritic cells in sarcoidosis. Thorax (2004) 0.96
Antiinflammatory effect of Graptophyllum pictum (L.) Griff. Chem Pharm Bull (Tokyo) (1989) 0.96
Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI. J Thromb Haemost (2009) 0.95
Expression of immediate early genes and vasopressin heteronuclear RNA in the paraventricular and supraoptic nuclei of rats after acute osmotic stimulus. J Neuroendocrinol (2005) 0.95
Effects of polyions on Japanese encephalitis virus: difference in interaction of virus with DEAE dextran and dextran sulfate between PS cell adapted and non-adapted virus. Arch Gesamte Virusforsch (1972) 0.95
Acetic, propionic, and oleic acid as the possible factors influencing the predominant residence of some species of Propionibacterium and coagulase-negative Staphylococcus on normal human skin. Can J Microbiol (1984) 0.94
Cofactor activity of dihydroflavin mononucleotide and tetrahydrobiopterin for murine epididymal indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun (1986) 0.94
Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn (1991) 0.93
Proteolytic processing of nuclear factor kappa B by calpain in vitro. FEBS Lett (1996) 0.93
Short- and long-term survival and prevalence of postoperative ileus after small intestinal surgery in the horse. Equine Vet J Suppl (2000) 0.93
Long-term ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion (1995) 0.93
Cytopathogenic protein in filtrates from cultures of Propionibacterium acnes isolated from patients with Kawasaki disease. Br Med J (Clin Res Ed) (1987) 0.93
Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost (2013) 0.92
Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity (2001) 0.92
D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berl) (1992) 0.92
Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2. Biochem J (2001) 0.92
Blood lead levels of the general populations of three Chinese cities. Sci Total Environ (1988) 0.91
Emphysematous pyelonephritis- conversion of type i to type II appearance on serial CT studies. Clin Imaging (2000) 0.91
Utilization of dihydroflavin mononucleotide and superoxide anion for the decyclization of L-tryptophan by murine epididymal indoleamine 2,3-dioxygenase. Arch Biochem Biophys (1987) 0.91
Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn (1993) 0.91
Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha. Infect Immun (1988) 0.90
Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells. J Rheumatol (1994) 0.90
Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J (1990) 0.90
Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood (1998) 0.90
Vibrational spectra of scissile bonds in enzyme active sites: a resonance Raman study of dithioacylpapains. Biochemistry (1982) 0.90
Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically diabetic KK-AY mice. Biosci Biotechnol Biochem (1996) 0.89
Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells. J Clin Endocrinol Metab (2000) 0.89
Near-infrared Fourier transform Raman spectroscopic study of cornea and sclera. Jpn J Ophthalmol (1994) 0.89
Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol (1995) 0.89
Studies on purothionin by chemical modifications. J Biochem (1982) 0.89
[Studies of platelet aggregation in six cases of EDTA-dependent pseudothrombocytopenia]. Rinsho Ketsueki (1994) 0.89
Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. FEBS Lett (2000) 0.89
Cyclosporin A and phenytoin modulate inflammatory responses. J Dent Res (2009) 0.89
Quantification of the minimal luminal cross-sectional area after coronary stenting by two- and three-dimensional intravascular ultrasound versus edge detection and videodensitometry. Am J Cardiol (1996) 0.88
Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system. Jpn J Pharmacol (2000) 0.88